Latest CyVek Inc. Stories

WALLINGFORD, Conn., Feb. 4, 2013 /PRNewswire/ -- CyVek, Inc., an innovator in multi-analyte immunoassay technology, announced today that it has secured a Series D round of financing in the amount of $5.5 million. Connecticut Innovations and a group of private investors participated in the round. The Series D funding enables the company to create the infrastructure needed to commercialize its novel immunoassay technology, CyPlex(TM), an integrated test system which includes a...